MicroRNA biomarkers in glioblastoma
- 23 May 2013
- journal article
- review article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 114 (1) , 13-23
Abstract
Recent research suggests that deregulation of microRNAs (miRNAs) is involved in initiation and progression of many cancers, including gliomas and that miRNAs hold great potential as future diagnostic and therapeutic tools in cancer. MiRNAs are a class of short non-coding RNA sequences (18–24 nucleotides), which base-pair to target messenger RNA (mRNA) and thereby cause translational repression or mRNA degradation based on the level of complementarity between strands. Profiling miRNAs in clinical glioblastoma samples has shown aberrant expression of numerous miRNAs when compared to normal brain tissues. Understanding these alterations is key to developing new biomarkers and intelligent treatment strategies. This review presents an overview of current knowledge about miRNA alterations in glioblastoma while focusing on the clinical future of miRNAs as biomarkers and discussing the strengths and weaknesses of various methods used in evaluating their expression.Keywords
This publication has 77 references indexed in Scilit:
- MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomasJournal of Neuro-Oncology, 2012
- Blood Alterations Preceding Clinical Manifestation of GlioblastomaCancer Investigation, 2012
- Alterations of MicroRNAs Contribute to Colon CarcinogenesisSeminars in Oncology, 2011
- Role of microRNAs in lymphoid biology and diseaseCurrent Opinion in Hematology, 2011
- Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastomaNucleic Acids Research, 2010
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- RNA-Seq: a revolutionary tool for transcriptomicsNature Reviews Genetics, 2009
- Up-regulation of micro-RNA-221 (miRNA-221; chr Xp11.3) and caspase-3 accompanies down-regulation of the survivin-1 homolog BIRC1 (NAIP) in glioblastoma multiforme (GBM)Journal of Neuro-Oncology, 2008
- Extensive modulation of a set of microRNAs in primary glioblastomaBiochemical and Biophysical Research Communications, 2005
- Detection of MicroRNAs and Assays to Monitor MicroRNA Activities In Vivo and In Vitro2005